The anti-inflammatory drug sodium salicylate inhibits nitric oxide formation induced by interleukin-1β at a translational step, but not at a transcriptional step, in hepatocytes

Hepatology

Volumn 25, Issue 2, 1997, Pages 416-420

  Sakitani, Kazushige ^a   Kitade, Hiroaki ^a   Inoue, Kyoichi ^a   Kamiyama, Yasuo ^a   Nishizawa, Mikio ^a   Okumura, Tadayoshi ^a   Ito, Seiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; NUCLEAR FACTOR; RECOMBINANT INTERLEUKIN 1; SALICYLATE SODIUM;

ANIMAL CELL; ARTICLE; CELL DAMAGE; ENDOTOXEMIA; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; INFLAMMATION; LIVER CELL; LIVER DYSFUNCTION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; TRANSLATION REGULATION;

EID: 0031014370     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250226     Document Type: Article

References (42)

1. Kurose I, Kato S, Ishii H, Fukumura D, Miura S, Suematsu M, Tsuchiya M. Nitric oxide mediates lipopolysaccharide-induced alteration of mitochondrial function in cultured hepatocytes and isolated perfused liver. HEPATOLOGY 1993;18:380-388.
2. Kim Y-M, Bergonia HA, Müller C, Pitt BR, Watkins WD, Lancaster JR Jr. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J Biol Chem 1995;270:5710-5713.
3. Billiar TR, Curran RD, Stuehr DJ, Stadler J, Simmons RL, Murray SA. Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. Biochem Biophys Res Commun 1990;168: 1034-1040.
4. Knowel RG, Merrett M, Salter M, Moncada S. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem J 1990;270:833-836.
5. Billiar TR, Curran RD, Ferrari FK, Williams DL, Simmons RL. Kupffer cells: hepatocyte cocultures release nitric oxide in response to bacterial endotoxin. J Surg Res 1990;48:349-353.
6. Spitzer JA. Cytokine stimulation of nitric oxide formation and differential regulation in hepatocytes and nonparenchymal cells of endotoxemic rats. HEPATOLOGY 1994;19:217-228.
7. Petros A, Bennett D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991;338:1557-1558.
8. Geller DA, Lowenstein CJ, Shapiro RA, Nusseler AK, Silvio MD, Wang ST, Nakayama DK, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993;90:3491-3495.
9. Curran RD, Billiar TR, Stuehr DJ, Ochoa JB, Harbrecht BB, Flint SG, Simmons RL. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg 1990;212: 462-471.
10. Wood ER, Berger H Jr, Sherman PA, Lapetina EG. Hepatocytes and macrophages express an identical cytokine inducible nitric oxide synthase gene. Biochem Biophys Res Commun 1993;191:767-774.
11. Nüssler AK, Geller DA, Sweetland MA, Silvio MD, Biliar TR, Madariaga JB, Simmons RL, et al. Induction of nitric oxide synthesis and its reactions in cultured human and rat hepatocytes stimulated with cytokines plus LPS. Biochem Biophys Res Commun 1993;194:826-835.
12. Nüssler AK, Liu Z-Z, Silvio MD, Sweetland MA, Geller DA, Lancaster JR Jr, Billiar TR, et al. Hepatocyte inducible nitric oxide synthase is influenced in vitro by cell density. Am J Physiol 1994;266:C394-C401.
13. Kitade H, Sakitani K, Inoue K, Masu Y, Kawada N, Hiramatsu Y, Kamiyama Y, et al. Interleukin-1β markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide, in primary cultured rat hepatocytes, but not in Kupffer cells. HEPATOLOGY 1996;23:797-802.
14. O'Neill LAJ. Towards an understanding of the signal transduction pathways for interleukin-1. Biochim Biophys Acta 1995;1266:31-44.
15. Xie Q-W, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. J Exp Med 1993;177:1779-1784.
16. Nunokawa Y, Ishida N, Tanaka S. Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem Biophys Res Commun 1994;200:802-807.
17. Kopp E, Ghosh S. Inhibition of NF-κB by NaSA and aspirin. Science 1994; 265:956-959.
18. 2 in primary cultured rat hepatocytes. Prostaglandins 1993;45:459-474.
19. Horiuti Y, Ogishima M, Yano K, Shibuya Y. Quantification of cell nuclei isolated from hepatocytes by cell lysis with nonionic detergent in citric acid. Cell Struct Funct 1991;16:203-207.
20. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [N]nitrate in biological fluids. Anal Biochem 1982;126:131-138.
21. Schreiber E, Matthias P, Müller MM, Schaffner W. Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
23. Nunokawa Y, Ishida N, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1993;191:89-94.
24. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature N Biol 1971;231:232-235.
25. Ku EC, Wasvary JM, Cash WD. Diclofenac sodium (GP 4584, Voltaren), a potent inhibitor of Prostaglandin synthetase. Biochem Pharmacol 1975; 24:641-643.
26. 2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci U S A 1994;91:12168-12172.
27. Takashiba S, van Dyke TE, Shapiro L, Amar S. Lipopolysaccharide-inducible and salicylate-sensitive nuclear factor on human tumor necrosis factor alpha promoter. Infect Immun 1995;63:1529-1534.
28. Arend WP. Interleukin 1 receptor antagonist; a new member of the interleukin 1 family. J Clin Invest 1991;88:1445-1451.
29. Kohira T, Matsumoto K, Ichihara A, Nakamura T. Identification of a biologically functional novel IL-1β-specific receptor on adult rat hepatocytes. J Biochem 1993;114:658-662.
30. Iwashita M, Hirata Y, Imai T, Sato K, Marumo F. Molecular cloning of endothelial, inducible nitric oxide synthase gene from rat aortic endothelial cell. Eur J Biochem 1996;237:668-673.
31. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986;46:659-667.
32. Kitade H, Kanemaki T, Sakitani K, Inoue K, Kamiya T, Nakagawa M, Hiramatsu Y, et al. Regulation of energy metabolism by interleukin-1β, but not by interleukin-6, is mediated by nitric oxide in primary cultured rat hepatocytes. Biochim Biophys Acta 1996;1311:20-26.
33. Laskin DL, Rodriguez del Valle M, Heck DE, Hwang S-M, Ohnishi ST, Durham SK, Goller NL, et al. Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression. HEPATOLOGY 1995;22:223-234.
34. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role of nitric oxide. Lancet 1991;337:776-778.
35. Whittle BJ, Moncada S. Nitric oxide the elusive mediator of the hyperdynamic circulation of cirrhosis. HEPATOLOGY 1992;16:1089-1092.
36. Castro A, Jimenez W, Claria J, Ros J, Martinez JM, Bosch M, Arroyo V, et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. HEPATOLOGY 1993;18:367-372.
37. Pizcueta P, Pique JM, Fernandez M, Bosch J, Rodes J, Whittle BJ, Moncada S. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992;103:1909-1915.
38. Claria J, Jimenez W, Ros J, Asbert M, Castro A, Arroyo V, Rivera F, et al. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. HEPATOLOGY 1992;15:343-349.
39. Dufour J-FJ, Turner TJ, Arias IM. Nitric oxide blocks bile canalicular contraction by inhibiting inositol triphosphate-dependent calcium mobilization. Gastroenterology 1995;108:841-849.
40. Nanji AA, Greenberg SS, Tahan SR, Fogt F, Loscalzo J, Sadrzadeh SMH, Xie J, et al. Nitric oxide production in experimental alcoholic liver disease in the rat: role in protection from injury. Gastroenterology 1995;109:899-907.
41. Kuo PC, Slivka A. Nitric oxide decreases oxidant-mediated hepatocyte injury. J Surg Res 1994;56:594-600.
42. Harbrecht BG, Stadler J, Demetris AJ, Simmons RL, Billiar TR. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol 1994;266:G1004-G1010.